Stryker Corporation (SYK) — Technical state
As of 2026-10-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
29.5% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip.
The moving-average stack
- vs 20-day+0.2%
- vs 50-day-9%
- vs 200-day-15.4%
- 52-week band29.5% off the high · +3.9% off the low
- Streak2 consecutive up sessions
- Stochastic%K 47.8 · %D 51.8 · down cross
Continue: the SYK chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-10-09
Quick answers
What is the current Closelooknet signal on SYK?
Resizing — 29.5% off its high — 29.5% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip. As of 2026-10-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is SYK above its 50-day and 200-day moving averages?
As of 2026-10-09, Stryker Corporation trades -9% below its 50-day and -15.4% below its 200-day average, with the 20-day +0.2% away.
How far is SYK from its 52-week high?
29.5% below the 52-week high and 3.9% above the 52-week low, as of 2026-10-09.
Related in the Closelooknet universe
same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- DXCM DexCom Inc
- RACE Ferrari NV
- DECK Deckers Outdoor Corporation
- LLY Eli Lilly and Company
- TOST Toast Inc
- FSLR First Solar Inc
- GMED Globus Medical
- REGN Regeneron Pharmaceuticals Inc
- ONON On Holding Ltd
- DB1.DE Deutsche Börse AG
- FAST Fastenal Company
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- CEVI.ST CellaVision ABindustry
- GKOS Glaukos Corpindustry
- SHL.DE Siemens Healthineers AGindustry
- PACB Pacific Biosciences of Californiaindustry
- TXG 10X Genomics Incindustry